Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo

M. B. Williams, Richard S Jope

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

The therapeutic effect of lithium in manic-depressive illness may involve alterations in the activity of the phosphoinositide second messenger system. Lithium administration to rats potentiates responses to cholinergic agonists, as evidenced by the production of seizures in lithium-treated rats after normally nonconvulsant doses of cholinergic agonists. We now report that lithium also potentiates the response to a serotonin (5-HT) agonist, DOI, that activates 5-HT2/5-HT(1C) receptors coupled to phosphoinositide hydrolysis. EEG recordings showed that administration of DOI (8 mg kg-1) to lithium-treated, but not to lithium-naive, rats caused seizures which were blocked by ritanserin pretreatment. These results demonstrate that lithium pretreatment causes a normally subconvulsive dose of serotonergic, in addition to cholinergic, agonists to induce seizures. Since DOI, like cholinergic agonists, activates receptors coupled with phosphoinositide hydrolysis and lithium potentiates responses to each, this second messenger system is likely to be involved in this effect of lithium.

Original languageEnglish
Pages (from-to)1118-1120
Number of pages3
JournalNeuroReport
Volume5
Issue number9
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Serotonin Receptors
Phosphatidylinositols
Lithium
Cholinergic Agonists
Seizures
Second Messenger Systems
Hydrolysis
Ritanserin
Serotonin Receptor Agonists
Therapeutic Uses
Electroencephalography
Serotonin

Keywords

  • bipolar affective disorder
  • lithium
  • phosphoinositide
  • seizures
  • serotonin

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo. / Williams, M. B.; Jope, Richard S.

In: NeuroReport, Vol. 5, No. 9, 01.01.1994, p. 1118-1120.

Research output: Contribution to journalArticle

@article{70b6c83a18344def9cde3d86ea8d5db0,
title = "Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo",
abstract = "The therapeutic effect of lithium in manic-depressive illness may involve alterations in the activity of the phosphoinositide second messenger system. Lithium administration to rats potentiates responses to cholinergic agonists, as evidenced by the production of seizures in lithium-treated rats after normally nonconvulsant doses of cholinergic agonists. We now report that lithium also potentiates the response to a serotonin (5-HT) agonist, DOI, that activates 5-HT2/5-HT(1C) receptors coupled to phosphoinositide hydrolysis. EEG recordings showed that administration of DOI (8 mg kg-1) to lithium-treated, but not to lithium-naive, rats caused seizures which were blocked by ritanserin pretreatment. These results demonstrate that lithium pretreatment causes a normally subconvulsive dose of serotonergic, in addition to cholinergic, agonists to induce seizures. Since DOI, like cholinergic agonists, activates receptors coupled with phosphoinositide hydrolysis and lithium potentiates responses to each, this second messenger system is likely to be involved in this effect of lithium.",
keywords = "bipolar affective disorder, lithium, phosphoinositide, seizures, serotonin",
author = "Williams, {M. B.} and Jope, {Richard S}",
year = "1994",
month = "1",
day = "1",
language = "English",
volume = "5",
pages = "1118--1120",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo

AU - Williams, M. B.

AU - Jope, Richard S

PY - 1994/1/1

Y1 - 1994/1/1

N2 - The therapeutic effect of lithium in manic-depressive illness may involve alterations in the activity of the phosphoinositide second messenger system. Lithium administration to rats potentiates responses to cholinergic agonists, as evidenced by the production of seizures in lithium-treated rats after normally nonconvulsant doses of cholinergic agonists. We now report that lithium also potentiates the response to a serotonin (5-HT) agonist, DOI, that activates 5-HT2/5-HT(1C) receptors coupled to phosphoinositide hydrolysis. EEG recordings showed that administration of DOI (8 mg kg-1) to lithium-treated, but not to lithium-naive, rats caused seizures which were blocked by ritanserin pretreatment. These results demonstrate that lithium pretreatment causes a normally subconvulsive dose of serotonergic, in addition to cholinergic, agonists to induce seizures. Since DOI, like cholinergic agonists, activates receptors coupled with phosphoinositide hydrolysis and lithium potentiates responses to each, this second messenger system is likely to be involved in this effect of lithium.

AB - The therapeutic effect of lithium in manic-depressive illness may involve alterations in the activity of the phosphoinositide second messenger system. Lithium administration to rats potentiates responses to cholinergic agonists, as evidenced by the production of seizures in lithium-treated rats after normally nonconvulsant doses of cholinergic agonists. We now report that lithium also potentiates the response to a serotonin (5-HT) agonist, DOI, that activates 5-HT2/5-HT(1C) receptors coupled to phosphoinositide hydrolysis. EEG recordings showed that administration of DOI (8 mg kg-1) to lithium-treated, but not to lithium-naive, rats caused seizures which were blocked by ritanserin pretreatment. These results demonstrate that lithium pretreatment causes a normally subconvulsive dose of serotonergic, in addition to cholinergic, agonists to induce seizures. Since DOI, like cholinergic agonists, activates receptors coupled with phosphoinositide hydrolysis and lithium potentiates responses to each, this second messenger system is likely to be involved in this effect of lithium.

KW - bipolar affective disorder

KW - lithium

KW - phosphoinositide

KW - seizures

KW - serotonin

UR - http://www.scopus.com/inward/record.url?scp=0028287225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028287225&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 1118

EP - 1120

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 9

ER -